Skip to content

A Multicenter Prospective Cohort Study on Screening, Diagnosis, and Evaluation of Fabry Disease

A Multicenter Prospective Cohort Study on Screening, Diagnosis, and Evaluation of Fabry Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092764
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry disease

Interventions

Case series:NA

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 85 years. 2. Patients diagnosed with Fabry disease.

Exclusion criteria

Exclusion criteria: 1. Patients unable to cooperate with clinical data collection and follow-up due to various reasons, such as severe cognitive impairment, deafness, or non-Chinese language proficiency. 2. Patients with an expected survival time of less than 6 months.

Design outcomes

Primary

MeasureTime frame
Five-year all-cause mortality;Composite endpoint of heart failure, stroke, and kidney transplantation or dialysis;

Secondary

MeasureTime frame
Cardiac death within 1 year;HF readmission within 1 year;Malignant ventricular arrhythmias occurring within 1 year: including recurrent episodes of sustained ventricular tachycardia with hemodynamic instability, ventricular flutter, and ventricular fibrillation;

Countries

China

Contacts

Public ContactYang Jiefu

Beijing Hospital

yangjiefu2011@126.com+86 136 0129 2259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026